Figures computed from official regulatory filings — methodology.
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
Create a free accountThis page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | |
|---|---|---|---|
| Other | $283.8K | SEC | |
| ExerciseD | — | SEC | |
| Exercise | — | SEC | |
| ExerciseD | — | SEC | |
| ExerciseD | — | SEC | |
| AwardD | $52.9K | SEC | |
| ExerciseD | — | SEC | |
| Exercise | — | SEC | |
| AwardD | $88.5K | SEC | |
| ExerciseD | — | SEC | |
| Other | $243.9K | SEC | |
| Other | $220.8K | SEC | |
| ExerciseD | — | SEC | |
| Exercise | — | SEC | |
| AwardD | $68.1K | SEC | |
| Buy | $20K | SEC | |
| Buy | $9.4K | SEC | |
| Buy | $50.5K | SEC | |
| Other | $220.8K | SEC | |
| Exercise | — | SEC | |
| AwardD | $68.1K | SEC | |
| ExerciseD | — | SEC | |
| Buy | $26.6K | SEC | |
| AwardD | $885.9K | SEC | |
| Buy | $14.3K | SEC |